Sort
10,766 grants matching “checkpoint inhibitor”
SPORE: Targeted Therapies for Glioma
$2,438,174Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2019 · CA
The Memorial Sloan Kettering Cancer Center SPORE in Pancreas Cancer
$2,434,565Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research · P50 · FY2025 · CA
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
$2,425,687Song Yao · Roswell Park Cancer Institute Corp · UH3 · FY2025 · CA
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
$2,421,788Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2021 · CA
Epigenetic Therapies - New Approaches
$2,421,039Jean-Pierre J Issa · Coriell Institute For Medical Research · P50 · FY2024 · CA
Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer
$2,420,487George J Weiner · University Of Iowa · P50 · FY2020 · CA
THE THERAPY OF AML
$2,404,845Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P01 · FY2007 · CA
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)
$2,403,307Paul Wesley Noble · Cedars-Sinai Medical Center · P01 · FY2018 · HL
THE THERAPY OF AML
$2,401,083Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P01 · FY2011 · CA
Liver Cancer Program
$2,400,798Anuradha Budhu · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Computational studies of cancer immunotherapy
$2,397,559Eytan Ruppin · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Identifying small molecules with therapeutic effects in RELAFus -driven EPN, mand testing them in preclinical genetically engineered models of EPN
$2,394,581Kevan M. Shokat · Fred Hutchinson Cancer Research Center · U54 · FY2019 · CA
Immunological Analysis of Brain Cancer
$2,394,103Masaki Terabe · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$2,387,152Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
$2,385,495Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2025 · CA
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
$2,384,337David A Barbie · Dana-Farber Cancer Inst · P50 · FY2022 · CA
Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
$2,382,404Eric P Winer · Dana-Farber Cancer Inst · P50 · FY2020 · CA
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
$2,375,289Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2023 · CA
Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer
$2,375,000George J Weiner · University Of Iowa · P50 · FY2017 · CA
SPORE in Gastrointestinal Cancers
$2,375,000Alison P Klein · Johns Hopkins University · P50 · FY2020 · CA
THE THERAPY OF AML
$2,374,635Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P01 · FY2008 · CA
Leveraging Observational (Real World) Data to Advance Precision Oncology
$2,372,456Charles L Sawyers · Sloan-Kettering Inst Can Research · P01 · FY2024 · CA
Yale SPORE in Skin Cancer
$2,369,171Marcus W Bosenberg · Yale University · P50 · FY2020 · CA
Adeno-associated Virus Biology And Utilization For Gene Transfer
$2,369,091Jay Chiorini · National Institute Of Dental & Craniofacial Research · ZIA · FY2019 · DE
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)
$2,368,307Paul Wesley Noble · Cedars-Sinai Medical Center · P01 · FY2019 · HL